Certara, Inc. (CERT)
$9.60+3.90%Close
BUYRECOVERY · day 1
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $1.5B
- Beta
- 1.43
- P/E (TTM)
- -21.65
- Short % float
- 25.79%
- Days to cover
- 9.0
- SI change
- -3.9%
- 1W
- +3.56%
- 1M
- +20.00%
- vs SPY 1W
- +3.70%
- vs SPY 1M
- +17.49%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 37
- VALUE
- 18
- GROWTH
- 47
- GARP
- 45
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC-4.0%
REV YoY-
ROE-6.7%
EPS YoY-
ROA-4.9%
GROSS58
OP2
NET-17
[VALUATION]
P/E TTM-21.65
P/E FWD27.90
SECTOR PE20.34
INDUSTRY PE24.21
P/B1.53
P/FCF-
EV/EBITDA15.71
EV/EBIT-
PEG2.00
FCF YIELD-
RISK
INT COV-
D/E30.19
ALTMAN Z-
CURR RATIO2.55
ND/EBITDA-
BETA1.43
Company news
FAQ
- What is LOPJLB’s current signal on CERT?
- LOPJLB’s latest quantitative signal on Certara, Inc. (CERT) is BUY in a RECOVERY regime. Signals are updated daily.
- What market regime is CERT in?
- Certara, Inc. (CERT) is currently classified in the RECOVERY HMM market regime on LOPJLB.
- What does Certara, Inc. (CERT) do?
- Certara, Inc. provides advanced software solutions and technology-driven services, specializing in biosimulation throughout the entire drug development lifecycle. From initial drug discovery and preclinical research to clinical trials, regulatory submissions, and market entry, the company's core mission is to accelerate the delivery of new medicines to patients by transforming these processes w…